International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 4 , Pages 1181-1186 , 15 November 2007

A Multicenter Phase II Study of Local Radiation Therapy for Stage IEA Mucosa-Associated Lymphoid Tissue Lymphomas: A Preliminary Report From the Japan Radiation Oncology Group (JAROG)

  • Koichi Isobe, M.D.

      Affiliations

    • Department of Radiology, Chiba University Hospital, Chiba, Japan
    • Corresponding Author InformationReprint requests to: Koichi Isobe, M.D., Department of Radiology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan. Tel: (+81) 43-226-2100; Fax: (+81) 43-226-2101
    • ,
  • Yoshikazu Kagami, M.D.

      Affiliations

    • Radiation Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Keiko Higuchi, M.D.

      Affiliations

    • Department of Radiology, Gunma Prefecture Cancer Center, Gunma, Japan
    • ,
  • Takeshi Kodaira, M.D.

      Affiliations

    • Department of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, Japan
    • ,
  • Masatoshi Hasegawa, M.D.

      Affiliations

    • Department of Radiation Oncology, Nara Medical University, Nara, Japan
    • ,
  • Naoto Shikama, M.D.

      Affiliations

    • Department of Radiology, Shinshu University School of Medicine, Matsumoto, Japan
    • ,
  • Masanori Nakazawa, M.D.

      Affiliations

    • Department of Radiology, Jichi Medical University, Tochigi, Japan
    • ,
  • Ichiro Fukuda, M.D.

      Affiliations

    • Department of Radiology, Jikei University School of Medicine, Tokyo, Japan
    • ,
  • Keiji Nihei, M.D.

      Affiliations

    • Radiation Oncology Division, National Cancer Center Hospital East, Chiba, Japan
    • ,
  • Kana Ito, M.D.

      Affiliations

    • Department of Radiology, Juntendo University School of Medicine, Tokyo, Japan
    • ,
  • Teruki Teshima, M.D.

      Affiliations

    • Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Osaka, Japan
    • ,
  • Yoshihiro Matsuno, M.D.

      Affiliations

    • Clinical Laboratory Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Masahiko Oguchi, M.D.

      Affiliations

    • Department of Radiologic Oncology, Cancer Institute Hospital, Tokyo, Japan

Received 6 March 2007 ,Revised 17 April 2007 ,Accepted 18 April 2007.

References 

  1. Isaacson PG, Wright D. Malignant lymphoma of mucosa-associated lymphoid tissue: A distinctive type of B-cell lymphoma. Cancer. 1983;52:1410–1416
  2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–1392
  3. Isaacson PG, Muller-Hermelink HK, Piris MA, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In:  Jaffe ES,  Harris NL,  Stein H,  Vardiman JW editor. World Health Organization classifications of tumors: Pathology and genetics of tumours of haematopoietic and lymphoid tissue. Lyon: IARC Press; 2001;p. 157–160
  4. Lymphoma Study Group of Japanese Pathologists: The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Pathol Int. 2000;50:696–702
  5. Isaacson PG. Gastric MALT lymphoma; from concept to cure. Ann Oncol. 1999;10:637–645
  6. Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior; analysis of 108 patients. J Clin Oncol. 1997;15:1624–1630
  7. Zinzani PL, Magagnoli M, Galieni P, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma; analysis of 75 patients. J Clin Oncol. 1999;17:1254–1258
  8. Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000;95:802–806
  9. Liao Z, Ha CS, McLaughlin P, et al. Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation; natural history and patterns of disease progression. Int J Radiat Oncol Biol Phys. 2000;48:399–403
  10. Jenkins C, Rose GE, Bunce C, et al. Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol. 2000;84:907–913
  11. Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa- associated lymphoid tissue. Blood. 2003;101:2489–2495
  12. Chao CK, Lin HS, Devineni VR, et al. Radiation therapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys. 1995;31:929–934
  13. Bolek TW, Moyses HM, Marcus RB, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys. 1999;44:31–36
  14. Pelloski CE, Wilder RB, Ha CS, et al. Clinical stage IEA–IIEA orbital lymphomas: Outcomes in the era of modern staging and treatment. Radiother Oncol. 2001;59:145–151
  15. Stafford SL, Kozelsky TF, Garrity JA, et al. Orbital lymphoma: Radiotherapy outcome and complications. Radiother Oncol. 2001;59:139–144
  16. Le QT, Eulau SM, George TI, et al. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys. 2002;52:657–663
  17. Fung CY, Tarbell NJ, Lucarelli MJ, et al. Ocular adnexal lymphoma: Clinical behavior of distinct world health organization classification subtypes. Int J Radiat Oncol Biol Phys. 2003;57:1382–1391
  18. Hasegawa M, Kojima M, Shioya M, et al. Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys. 2003;57:172–176
  19. Martinet S, Ozsahin M, Belkacemi Y, et al. Outcome and prognostic factor in orbital lymphoma: A rare cancer network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55:892–898
  20. Olivier KR, Brown PD, Stafford SL, et al. Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland. Int J Radiat Oncol Biol Phys. 2004;60:1510–1514
  21. Zhou P, Ng AK, Silver B, et al. Radiation therapy for orbital lymphoma. Int J Radiat Oncol Biol Phys. 2005;63:866–871
  22. Wenzel C, Fiebiger W, Dieckmann K, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area. Cancer. 2003;67:2236–2241
  23. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Stage I and II MALT lymphoma: Results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys. 2001;50:1258–1264
  24. Hitchcock S, Ng AK, Fisher DC, et al. Treatment outcome of mucosa-associated lymphoid tissue/ marginal zone non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2002;52:1058–1066
  25. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent outcome. J Clin Oncol. 2003;21:4157–4164
  26. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998;16:1916–1921
  27. Fung CY, Grossbard ML, Linggood RM, et al. Mucosa-associated lymphoid tissue lymphoma of the stomach. Cancer. 1999;85:9–17
  28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  29. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol. 1999;17:1233–1253
  30. Uno T, Isobe K, Shikama N, et al. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa. Cancer. 2003;98:865–871
  31. Pfeffer MR, Rabin T, Tsvang L, et al. Orbital lymphoma: Is it necessary to treat the entire orbit?. Int J Radiat Oncol Biol Phys. 2004;60:527–530
  32. Schechter NR, Yahalom J. Low-grade MALT lymphoma of the stomach: A review of treatment options. Int J Radiat Oncol Biol Phys. 2000;46:1093–1103
  33. Bertoni F, Zucca E. State-of-the-art therapeutics: Marginal zone lymphoma. J Clin Oncol. 2005;23:6415–6420
  34. Ferreri AJ, Ponzoni M, Guidoboni M, et al. A critical review of the effect of Helicobacter pylori eradication on gastric MALT lymphoma. Curr Gastroenterol Rep. 2002;2:494–498
  35. Morgner A, Miehlke S, Fischach W, et al. Complete remission of primary gastric high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol. 2001;19:2041–2048
  36. Chen LT, Lin JT, Shyu RY, et al. Prospective study of Helicobacter pylori eradication therapy in stage IE high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol. 2001;19:4245–4251
  37. Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004;96:586–594
  38. Lettini AA, Demeter J, Dell'Oro S, et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci–eradicating antibiotic therapy. J Clin Oncol. 2005;23:5067–5073
  39. Kutting B, Bonsmann G, Metze D, et al. Borrelia burgdorferi associated primary cutaneous B cell lymphoma: Complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol. 1997;36:311–314
  40. Roggero E, Zucca E, Mainetti C, et al. Eradiation of Borrelia burgdorferi infection in primary marginal zone B–cell lymphoma of the skin. Hum Pathol. 2000;31:263–268
  41. Thiede C, Wundisch T, Alpen B, et al. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol. 2001;19:1600–1609
  42. Rosado MF, Byrne GE, Ding F, et al. Ocular adnexal lymphoma: A clinicopathologic study of a large cohort of patients with no evidence for an association with. Chlamydia psittaci. Blood. 2006;107:467–472
  43. Cremoux P, Subtil A, Ferreri AJ, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphoma. J Natl Cancer Inst. 2006;98:365–366
  44. Grunberger B, Hauff W, Lukas J, et al. ‘Blind’ antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa. Ann Oncol. 2006;17:484–487
  45. Joger G, Neumeister P, Brezinschek R, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: A phase II study. J Clin Oncol. 2002;20:3872–3877
  46. Zinzani PL, Stefoni V, Musuraca G, et al. Fludarabine-containing chemotherapy as frontline treatment on nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer. 2004;100:2190–2194
  47. Conconi A, Martinelli G, Thieblemnt C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 2003;102:2741–2745
  48. Martinelli G, Laszlo D, Ferreri AJ, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti–Helicobacter pylori therapy. J Clin Oncol. 2005;23:1979–1983
  49. Raderer M, Streubel B, Woehrer S, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res. 2005;11:3349–3352

 This study was supported by a Grant-in-Aid for Cancer Research (12-13, 16-12) from the Ministry of Health, Labour and Welfare, Japan.

 Conflict of interest: none.

PII: S0360-3016(07)00700-6

doi: 10.1016/j.ijrobp.2007.04.029

International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 4 , Pages 1181-1186 , 15 November 2007

Article Tools

* Image Usage & Resolution